EMA: EU – US Mutual Recognition Agreement for Veterinary Medicines Inspections
The mutual recognition of inspections of certain veterinary medicines between the European Union and the United States has reached a significant milestone: On 31 May 2023, the US FDA recognised the capability of 16 EU Member States to carry out GMP inspections for certain veterinary products at a level equal to the US. At the same time, the EU also recognised the FDA as an equivalent authority for GMP inspections of sites manufacturing veterinary medicines.
The Member States whose GMP inspections for veterinary medicines are recognised by the FDA are Austria, Belgium, Bulgaria, Denmark, Estonia, Finland, France, Greece, Hungary, Ireland, Luxembourg, Netherlands, Poland, Portugal, Slovenia, and Spain. A timely assessment of the remaining 11 competent authorities of Member States is projected.
Two Q&A documents have been revised, accordingly:
- Q&A on the impact of the EU-USA Mutual Recognition Agreement on marketing authorisation applications and relevant variations
- Q&A on the impact of the Mutual Recognition Agreement (MRA) between the European Union and the United States as of 31 May 2023
Source:
EMA: News and Events
Meet the GMP Compliance Adviser
The GMP Compliance Adviser is the world's largest knowledge portal for quality management in the pharma business.
The demo access is non-binding and ends automatically.
You may also be interested in the following articles:
